New Zealand - Re-Export of Insulin in Dosage Forms
Since 2014, New Zealand Re-Export of Insulin in Dosage Forms increased 1.7% year on year. In 2019, the country was number 7 comparing other countries in Re-Export of Insulin in Dosage Forms at $285,616.07. New Zealand is overtaken by Canada, which was ranked number 6 with $1,644,202.25 and is followed by Kenya with $38,701.55. United Arab Emirates lead the ranking with $37,345,759.11 in 2019, a decrease of 4.3% compared to 2018. United States, Jordan and Saudi Arabia respectively ranked number 2, 3 and 4 in this ranking. United Arab Emirates recorded the best 5 years average growth at +119.7% per year, while Canada was the worst growing country at -13.3% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 285,616.07 |
| 2018 | 241,806.88 |
| 2017 | 329,952.28 |
| 2016 | 265,655.59 |
| 2015 | 194,588.64 |
Download all data from 1990 to 2019
How does New Zealand rank in Re-Export of Insulin in Dosage Forms?
| # | 10 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United Arab Emirates
|
37,345,759.11 | 2019 | -4.3 % | +119.7 % | View data | |
| 2 |
#2
United States
|
6,604,316.00 | 2019 | -8.0 % | +47.1 % | View data | |
| 6 |
#6
Canada
|
1,644,202.25 | 2019 | -46.0 % | -13.3 % | View data | |
| 7 |
#7
New Zealand
|
285,616.07 | 2019 | +18.1 % | +1.7 % | View data | |
| 8 |
#8
Kenya
|
38,701.55 | 2018 | +992.7 % | NA | View data | |